SCA
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA) (NCT06034886) | Biohaven Pharmaceuticals, Inc. |
Track SCA automatically
Every clearance here is in the API, with alerts when new ones post.